Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-006348
Filing Date
2025-04-28
Accepted
2025-04-28 08:32:36
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm   iXBRL DEF 14A 623569
2 proxy_001.jpg GRAPHIC 659969
3 proxy_002.jpg GRAPHIC 539688
  Complete submission text file 0001641172-25-006348.txt   4241325

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gctk-20241231.xsd EX-101.SCH 4704
5 XBRL DEFINITION FILE gctk-20241231_def.xml EX-101.DEF 8489
6 XBRL LABEL FILE gctk-20241231_lab.xml EX-101.LAB 59988
7 XBRL PRESENTATION FILE gctk-20241231_pre.xml EX-101.PRE 41260
20 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 74208
Mailing Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070
Business Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070 972 (8) 675-7878
Glucotrack, Inc. (Filer) CIK: 0001506983 (see all company filings)

EIN.: 980668934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41141 | Film No.: 25876205
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)